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The glomerular ﬁltration rate (GFR) cannot be measured by
direct means, but can be assessed by urinary clearance of
exogenous ﬁltration markers such as inulin, iohexol, or iotha-
lamate [1,2]. However, for several reasons, direct GFR mea-
surements are not suitable for use in routine laboratory
settings. Hence, it is more appropriate to derive an estimated
GFR (eGFR) from various equations. However, recent reports
have shown that these equations are inadequate and have
greater biases in Asian populations [3].
Recently Lee et al [4] evaluated the performance of serum
cystatin C-based equations in calculating GFR in chronic
kidney disease (CKD) patients. As the Modiﬁcation of Diet in
Renal Disease (MDRD) eGFR equation is known to be inaccu-
rate in Asians [3], I fully agree with the authors’ concept to ﬁnd
out the optimal eGFR equation. They suggest that the perfor-
mance of equations varied based on the CKD stages. However,
it is difﬁcult to determine the real superiority of any equation
among them, mainly due to a lack of measured GFR (mGFR)
data [5].
Although the authors showed that the Orebro-cyst (Gen-
tian) method was compatible with the results of MDRD
equation in CKD stage 4–5, it does not mean that this method
is more suitable for the evaluation of eGFR in patients of this
stage. In Fig. 2 of that paper, discrepancy between cystatin-
C-based eGFR and creatinine-based eGFR is generally very
high; thus again, it is difﬁcult to draw a meaningful conclusion
regarding the optimal eGFR equation. For proper comparison, I
would like to suggest that the authors should further study the
performance of the equations using any type(s) of mGFR
evaluation methods, such as radioisotope- or inulin-based
methods.Conﬂict of interest
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In Reply:
We appreciate your interest in our recent article entitled
“Comparison of glomerular ﬁltration rates calculated by dif-
ferent serum cystatin C-based equations in patients with
chronic kidney disease”. Traditionally, for most clinical circum-
stances, glomerular ﬁltration rate (GFR) had been estimated
from serum creatinine (SCr, eGFRcr). However, SCr concentra-
tion is inﬂuenced by non-GFR determinants, including muscle
mass, diet, tubular secretion and extra-renal elimination by
the gastrointestinal tract. Currently the Kidney Disease:
Improving Global Outcomes (KDIGO) guidelines recommend
initial use of SCr followed by a conﬁrmatory test using cystatin
C for evaluation of GFR when eGFRcr is thought to be
inaccurate [1]. But recent published data suggested that, the
combined creatinine-cystatin C based Chronic Kidney Disease
Epidemiology Collaboration (CKD-EPI) equation is more useful
as a conﬁrmatory test than the equations based on SCr or
cystatin C alone [2,3]. Although cystatin C is less affected by
racial differences, race is still an important determinant of GFR
estimation [4]. Thus, race-speciﬁc modiﬁcation is necessaryed by Elsevier. This is an open access article under the CC BY-NC-ND
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compared six-different cystatin C based eGFR equations and
tried to ﬁnd out more suitable cystatin C based eGFR equation
in Korean CKD patients [5]. However, as you pointed out, we
could not draw a conclusion because we did not measure the
reference GFR. Thus, we fully agree with your suggestion that
further studies are required to decide which of the equation is
more suitable for the Korean CKD patients. In our study, we
found that performance of serum cystatin C is quite different
to that of SCr in patients with CKD stage 4 to 5 [5], and we
thought this ﬁnding might be associated with the extrarenal
elimination of serum cystatin C [6]. However, in other large
studies, this point has not been carefully evaluated [2,3]. Thus,
in our next study, we will focus more on the performance of
eGFRcys in patients with CKD stage 4 to 5, and compare its
accuracy to that of eGFRcr in those patients.Conﬂict of interest
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